Indication

Chronic Kidney Disease Associated Moderate to Severe Pruritus

1 clinical trial

2 products

Clinical trial

A Multicenter, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Nemolizumab in Subjects With Chronic Kidney Disease With Associated Moderate to Severe Pruritus

Status: Completed, Estimated PCD: 2024-01-03

Product

Product